Nunn Jason Raleigh (CIK 1444319) reported 5 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell ADXN (219,561 shares), Buy ADXN (219,561 shares), Buy ZBIO (63,158 shares), Sell RGLS (62,500 shares), Buy RGLS (62,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Addex Therapeutics Ltd. (ADXN) | Director | Sell | 219,561 | $0 |
| 2026-09-04 | Addex Therapeutics Ltd. (ADXN) | Director | Buy | 219,561 | $0 |
| 2025-10-14 | Zenas BioPharma, Inc. (ZBIO) | Director | Buy | 63,158 | $1.2M |
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | Director | Sell | 62,500 | $0 |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 62,500 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04